ESCCardiology2023New Guideline
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2023
Published by European Society of Cardiology · 128 pages · Class I
14New Class I Recs
9Societies Involved
38%Evidence Level A
Summary
Free previewThe 2023 ESC Heart Failure Guidelines update the evidence base for four-pillar therapy (ARNI, beta-blocker, MRA, SGLT2-i) and extend recommendations to HFpEF with empagliflozin and dapagliflozin. Simultaneous low-dose initiation is now preferred over sequential up-titration.
Heart FailureHFrEFHFpEFSGLT2iARNIFour-pillar therapy
Key Recommendations
Evidence Grading & Drug Doses
What's New vs Previous Version
Implementation & Clinical Pearls
Full guideline access requires an account
Create a free Prognia account to read the complete guideline — including all recommendations, evidence tables, drug dosing, and clinical pearls.
Full guideline text with all recommendations
Evidence grades (Class I/II/III, Level A/B/C)
AI-generated summary and clinical pearls
Auto-logged as CPD/CME activity
Free plan includes 10 guideline reads per day · No credit card required